Site-specific DNA-doxorubicin conjugates display enhanced cytotoxicity to breast cancer cells.
about
Nucleic Acid Bioconjugates in Cancer Detection and Therapy.Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing.All-Atom MD Predicts Magnesium-Induced Hairpin in Chemically Perturbed RNA Analog of F10 Therapeutic.Supramolecular aptamer nano-constructs for receptor-mediated targeting and light-triggered release of chemotherapeutics into cancer cells.All-Atom Molecular Dynamics Reveals Mechanism of Zinc Complexation with Therapeutic F10.
P2860
Site-specific DNA-doxorubicin conjugates display enhanced cytotoxicity to breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Site-specific DNA-doxorubicin ...... xicity to breast cancer cells.
@en
Site-specific DNA-doxorubicin ...... xicity to breast cancer cells.
@nl
type
label
Site-specific DNA-doxorubicin ...... xicity to breast cancer cells.
@en
Site-specific DNA-doxorubicin ...... xicity to breast cancer cells.
@nl
prefLabel
Site-specific DNA-doxorubicin ...... xicity to breast cancer cells.
@en
Site-specific DNA-doxorubicin ...... xicity to breast cancer cells.
@nl
P2093
P2860
P356
P1476
Site-specific DNA-doxorubicin ...... oxicity to breast cancer cells
@en
P2093
Christopher H Stuart
Mark O Lively
Michael J Thomas
William H Gmeiner
P2860
P304
P356
10.1021/BC4005427
P577
2014-02-06T00:00:00Z